| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |